Who owns ETF AMPLIFY TR TREATMENTS TESTING & ADVANCEMEN?
- Ticker: GERM
- CUSIP Number: 032108581
Tip: Access positions for across all investors
Analyze quarterly positions in Etf Amplify Tr Treatments Testing & Advancemen with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Etf Amplify Tr Treatments Testing & Advancemen stock
Who bought or sold ETF AMPLIFY TR TREATMENTS TESTING & ADVANCEMEN this quarter?
There are no current stakeholders of Etf Amplify Tr Treatments Testing & Advancemen.
This is normal when the security:
- Has been acquired or taken private
- Has merged with another entity
- Has changed its name and has a new CUSIP (and/or symbol)
- Has been delisted and the ticker has changed
Please use Search to find the security you were looking for.
Who sold out of Etf Amplify Tr Treatments Testing & Advancemen?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Susquehanna International | Jun 2024 | 47k | $850k |
| Citadel Advisors | Jun 2024 | 28k | $515k |
| Federation des caisses Desjardins du Quebec | Jun 2024 | 1.5k | $27k |
| UBS Group | Jun 2024 | 487.00 | $8.9k |
| Steward Partners Investment Advisory | Jun 2024 | 160.00 | $2.9k |